AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32792446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide 120 mg, administered as subcutaneous injections every 28 days for 72 weeks
Number of subjects: 44
Study 32792446 — intervention group
Group type: COMPARATOR
Intervention: Placebo, administered as subcutaneous injections every 28 days for 72 weeks
Number of subjects: 44
Study 32792446 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanreotide 120 mg
Number of subjects: 44
Study 32792446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 33878969 — intervention group
Group type: EXPERIMENTAL
Intervention: MBSR‐MC (Mindfulness-Based Stress Reduction for Military Cadets)
Number of subjects: 60
Study 33878969 — intervention group
Group type: COMPARATOR
Intervention: Control group (no experimental treatment)
Number of subjects: 60
Study 34102153 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% Povidone-Iodine (PVP-I)
Number of subjects: 56
Study 34102153 — intervention group
Group type: COMPARATOR
Intervention: Artificial Tears (AT)
Number of subjects: 56
Study 33706823 — intervention group
Group type: EXPERIMENTAL
Intervention: Restriction paired with incentive (not allowed to buy FAS with benefits and 30% financial incentive on eligible F/V)
Number of subjects: 254
Study 33706823 — intervention group
Group type: EXPERIMENTAL
Intervention: Restriction (not allowed to buy FAS with benefits)
Number of subjects: 254
Study 33706823 — intervention group
Group type: COMPARATOR
Intervention: Control (same food purchasing rules as SNAP)
Number of subjects: 254
Study 33971295 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month sedentary behavior reduction intervention
Number of subjects: 300
Study 33971295 — intervention group
Group type: EXPERIMENTAL
Intervention: Sit-stand desk attachment, wrist-worn activity prompter, behavioral counseling every two weeks, and twice-weekly automated text messages
Number of subjects: 300
Study 33211503 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjective quality of sleep in PD
Number of subjects: 106
Study 33211503 — intervention group
Group type: EXPERIMENTAL
Intervention: Actigraphic-measured sleep duration and efficiency in PD
Number of subjects: 106
Study 33211503 — intervention group
Group type: COMPARATOR
Intervention: Circadian rhythm disruption in HC
Number of subjects: 106
Study 33211503 — intervention group
Group type: EXPERIMENTAL
Intervention: Actigraphy-derived sleep efficiency
Number of subjects: 106
Study 33211503 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affect
Number of subjects: 106
Study 34006559 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment at the hospitals
Number of subjects: 2702
Study 34006559 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 2702
Study 32856353 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management intervention program
Number of subjects: 170
Study 32856353 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 170
Study 36315180 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided online self-navigation
Number of subjects: 407
Study 36315180 — intervention group
Group type: COMPARATOR
Intervention: In-person social care assistance
Number of subjects: 407
Study 36315180 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall engagement with offered assistance
Number of subjects: 407
Study 36315180 — intervention group
Group type: EXPERIMENTAL
Intervention: Using assistance for medications
Number of subjects: 407
Study 36315180 — intervention group
Group type: EXPERIMENTAL
Intervention: Using assistance for blood glucose supplies
Number of subjects: 407
Study 36315180 — intervention group
Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 407
Study 36315180 — intervention group
Group type: EXPERIMENTAL
Intervention: Being out of the workforce
Number of subjects: 407
Study 33309635 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month exercise training
Number of subjects: 20
Study 33309635 — intervention group
Group type: COMPARATOR
Intervention: Non-Exercise group
Number of subjects: 20
Study 33220426 — intervention group
Group type: EXPERIMENTAL
Intervention: GLS-guided cardioprotective therapy (CPT) initiation based on ≥12% relative reduction in GLS (n=166)
Number of subjects: 331
Study 33220426 — intervention group
Group type: COMPARATOR
Intervention: EF-guided cardioprotective therapy (CPT) initiation based on >10% absolute reduction of LVEF (n=165)
Number of subjects: 331
Study 33220426 — intervention group
Group type: EXPERIMENTAL
Intervention: GLS-guided CPT
Number of subjects: 331
Study 33220426 — intervention group
Group type: COMPARATOR
Intervention: EF-guided CPT
Number of subjects: 331
Study 33220426 — intervention group
Group type: COMPARATOR
Intervention: CPT in EF-guided arm
Number of subjects: 331
Study 33220426 — intervention group
Group type: EXPERIMENTAL
Intervention: CPT in GLS-guided arm
Number of subjects: 331
Study 32293509 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel patient information resource (website and booklet)
Number of subjects: 62
Study 32293509 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62
Study 32293509 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trial participation
Number of subjects: 62
Study 32293509 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment
Number of subjects: 62
Study 32293509 — intervention group
Group type: EXPERIMENTAL
Intervention: Web analytics
Number of subjects: 62
Study 36305922 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft tissue graft substitute
Number of subjects: 0
Study 36305922 — intervention group
Group type: COMPARATOR
Intervention: Wound dressing (control)
Number of subjects: 0
Study 34624757 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 (capecitabine 1800 mg + cyclophosphamide 80 mg)
Number of subjects: 144
Study 34624757 — intervention group
Group type: EXPERIMENTAL
Intervention: D3 (capecitabine 2200 mg + cyclophosphamide 100 mg)
Number of subjects: 144
Study 34624757 — intervention group
Group type: COMPARATOR
Intervention: D1 (capecitabine 1400 mg + cyclophosphamide 60 mg)
Number of subjects: 144
Study 35108265 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted lobectomy
Number of subjects: 186
Study 35108265 — intervention group
Group type: COMPARATOR
Intervention: Video-assisted lobectomy
Number of subjects: 186
Study 34020672 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 58
Study 34020672 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injections
Number of subjects: 58
Study 35670115 — intervention group
Group type: COMPARATOR
Intervention: iv metoclopramide (0.2 mg/kg) and placebo
Number of subjects: 53
Study 35670115 — intervention group
Group type: EXPERIMENTAL
Intervention: iv metoclopramide (0.2 mg/kg) and ketorolac (0.5 mg/kg)
Number of subjects: 53
Study 34107740 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Decision Aid (IDeA)
Number of subjects: 66
Study 34107740 — intervention group
Group type: COMPARATOR
Intervention: Usual care (clinician discretion)
Number of subjects: 66
Study 35994031 — intervention group
Group type: EXPERIMENTAL
Intervention: vCCC (virtual collaborative care clinic)
Number of subjects: 31
Study 35994031 — intervention group
Group type: COMPARATOR
Intervention: usual care
Number of subjects: 31
Study 33792729 — intervention group
Group type: EXPERIMENTAL
Intervention: Prothrombin complex concentrate (PCC) 1500 IU for patients ≤60 kg and 2000 IU for patients >60 kg
Number of subjects: 101
Study 33792729 — intervention group
Group type: COMPARATOR
Intervention: Frozen Plasma (FP) 3 U for patients ≤60 kg and 4 U for patients >60 kg
Number of subjects: 101
Study 32035876 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of XueShuanTong (150 mg/person)
Number of subjects: 0
Study 32035876 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion of XueShuanTong (150 mg/person)
Number of subjects: 0
Study 36201819 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher classroom management program
Number of subjects: 0
Study 36201819 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 34639560 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Resistance Training (CRT) program
Number of subjects: 22
Study 34639560 — intervention group
Group type: COMPARATOR
Intervention: Usual training (Control Group)
Number of subjects: 22
Study 32367309 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinacalcet
Number of subjects: 0
Study 35029590 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 weeks of resistance exercise
Number of subjects: 40
Study 35029590 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (CON)
Number of subjects: 40
Study 32048134 — intervention group
Group type: EXPERIMENTAL
Intervention: Sn150 kVp group (1/2th radiation dose level/150 kVp with a tin filter/2.34 mGy)
Number of subjects: 150
Study 32048134 — intervention group
Group type: COMPARATOR
Intervention: Sn100 kVp group (1/10th radiation dose level/100 kVp with a tin filter/0.47 mGy)
Number of subjects: 150
Study 32048134 — intervention group
Group type: COMPARATOR
Intervention: 120 kVp group (standard radiation dose/tube voltage, 120 kVp/CT volume dose index, 4.68 mGy)
Number of subjects: 150
Study 35849051 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational therapy using Ayres Sensory Integration
Number of subjects: 17
Study 35849051 — intervention group
Group type: COMPARATOR
Intervention: Usual therapeutic and educational services
Number of subjects: 17
Study 33047971 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI‐guided parathyroidectomy
Number of subjects: 67
Study 33047971 — intervention group
Group type: COMPARATOR
Intervention: Total parathyroidectomy plus forearm transplantation
Number of subjects: 67
Study 33047971 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 67
Study 35395815 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance garment
Number of subjects: 15
Study 35395815 — intervention group
Group type: COMPARATOR
Intervention: Running shorts (control)
Number of subjects: 15
Study 33174528 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial-impregnated peripherally inserted central venous catheter (coated with rifampicin-miconazole)
Number of subjects: 861
Study 33174528 — intervention group
Group type: COMPARATOR
Intervention: Standard peripherally inserted central venous catheter
Number of subjects: 861
Study 33174528 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial-impregnated peripherally inserted central venous catheter
Number of subjects: 861
Study 35198576 — intervention group
Group type: COMPARATOR
Intervention: Group RD1: 20 mL of 0.5% ropivacaine with 5 mg of dexamethasone and 0.5 μg·kg−1 DEX
Number of subjects: 95
Study 35198576 — intervention group
Group type: EXPERIMENTAL
Intervention: Group RD2: 20 mL of 0.5% ropivacaine with 5 mg of dexamethasone and 1 μg·kg−1 DEX
Number of subjects: 95
Study 32945777 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive psychology intervention
Number of subjects: 166
Study 32945777 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable wrist sensors
Number of subjects: 166
Study 32945777 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care utilization data
Number of subjects: 166
Study 32945777 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 166
Study 32272848 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR) with SAPIEN 3 valve
Number of subjects: 1000
Study 32272848 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 1000
Study 35229220 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication group (Paracetamol given 1 hour before debonding)
Number of subjects: 140
Study 35229220 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger pressure group
Number of subjects: 140
Study 35229220 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress relief group
Number of subjects: 140
Study 35229220 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study 36223862 — intervention group
Group type: EXPERIMENTAL
Intervention: Video recording of performance with verbal feedback
Number of subjects: 23
Study 36223862 — intervention group
Group type: COMPARATOR
Intervention: Verbal feedback only (Control)
Number of subjects: 23
Study 33871240 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercises (ten-week incremental endurance-resistance training, three sessions a week)
Number of subjects: 24
Study 32729222 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with pioglitazone plus weekly exenatide
Number of subjects: 331
Study 32729222 — intervention group
Group type: COMPARATOR
Intervention: Basal/bolus insulin therapy
Number of subjects: 331
Study 35193665 — intervention group
Group type: EXPERIMENTAL
Intervention: Tengfu Jiangya tablet (TJT) combined with valsartan/amlodipine (Val/Aml) 80/5 mg
Number of subjects: 288
Study 35193665 — intervention group
Group type: COMPARATOR
Intervention: Placebo combined with valsartan/amlodipine (Val/Aml) 80/5 mg
Number of subjects: 288
Study 33664472 — intervention group
Group type: EXPERIMENTAL
Intervention: sucrose 24% liquid with non‐nutritive sucking
Number of subjects: 195
Study 33664472 — intervention group
Group type: EXPERIMENTAL
Intervention: sucrose 24% gel with non‐nutritive sucking
Number of subjects: 195
Study 33664472 — intervention group
Group type: COMPARATOR
Intervention: breastfeeding
Number of subjects: 195
Study 32631651 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiautomatic needle segmentation algorithm
Number of subjects: 7
Study 32631651 — intervention group
Group type: COMPARATOR
Intervention: Manual segmentation
Number of subjects: 7
Study 33433559 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 49331
Study 33433559 — intervention group
Group type: COMPARATOR
Intervention: Usual activity comparison (Control)
Number of subjects: 49331
Study 32819680 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy with Defibrillator (CRT-D)
Number of subjects: 1381
Study 32819680 — intervention group
Group type: COMPARATOR
Intervention: Implantable Cardiac Defibrillator (ICD)
Number of subjects: 1381
Study 32819680 — intervention group
Group type: EXPERIMENTAL
Intervention: 6MWT
Number of subjects: 1381
Study 36038181 — intervention group
Group type: COMPARATOR
Intervention: BDQ, Pa and LZD 600 mg daily for 26 weeks (Control arm)
Number of subjects: 0
Study 36038181 — intervention group
Group type: EXPERIMENTAL
Intervention: BDQ, Pa and LZD 600 mg for 9 weeks followed by 300 mg for 17 weeks (Intervention arm 2)
Number of subjects: 0
Study 36038181 — intervention group
Group type: EXPERIMENTAL
Intervention: BDQ, Pa and LZD 600 mg for 13 weeks followed by 300 mg for 13 weeks (Intervention arm 3)
Number of subjects: 0
Study 36038181 — intervention group
Group type: EXPERIMENTAL
Intervention: All arms (including control)
Number of subjects: 0
Study 34412146 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern-oriented approaches using multivariate data analysis on chromatographic/spectroscopic fingerprints
Number of subjects: 0
Study 34412146 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional approaches for quality control of herbal medicines
Number of subjects: 0
Study 34412146 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic methods for plant material/plant extract authentication
Number of subjects: 0
Study 34412146 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound-oriented approach
Number of subjects: 0
Study 33483776 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused electromagnetic high‐energetic ESWT (2000 shots, 3 Hz, 0.35 mJ/mm2/hand, Storz Duolith SD1, n = 27)
Number of subjects: 52
Study 33483776 — intervention group
Group type: COMPARATOR
Intervention: Placebo ESWT (2000 shots, 3 Hz, 0.01 mJ/mm2/hand, n = 25)
Number of subjects: 52
Study 32008396 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT‐GSH plus Noom Monitor
Number of subjects: 225
Study 32008396 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 225
Study 36972286 — intervention group
Group type: EXPERIMENTAL
Intervention: Etodolac 200 mg (single dose)
Number of subjects: 15
Study 36972286 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg (single dose)
Number of subjects: 15
Study 36972286 — intervention group
Group type: EXPERIMENTAL
Intervention: Etodolac 200 mg (four-fold dose)
Number of subjects: 15
Study 36972286 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib 200 mg (four-fold dose)
Number of subjects: 15
Study 33063412 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedical intervention (TM) using non-invasive devices for daily monitoring of electrocardiogram, blood pressure, and body weight; duration: 12 months.
Number of subjects: 710
Study 33063412 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC); duration: 12 months.
Number of subjects: 710
Study 32381820 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10)
Number of subjects: 30
Study 32381820 — intervention group
Group type: COMPARATOR
Intervention: Methyl cellulose (Control)
Number of subjects: 30
Study 35810769 — intervention group
Group type: EXPERIMENTAL
Intervention: pTBI + hNSCs at maximum tolerated dose (MTD)
Number of subjects: 40
Study 35810769 — intervention group
Group type: COMPARATOR
Intervention: pTBI + vehicle
Number of subjects: 40
Study 33262230 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity progressive aerobic exercise (PAE) for 24 weeks
Number of subjects: 86
Study 33262230 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (habitual lifestyle)
Number of subjects: 86
Study 36343653 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised cooler dialysate (mean dialysate temperature 35·8°C)
Number of subjects: 15413
Study 36343653 — intervention group
Group type: COMPARATOR
Intervention: Standard temperature dialysate (36·5°C)
Number of subjects: 15413
Study 36343653 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalised cooler dialysate
Number of subjects: 15413
Study 36343653 — intervention group
Group type: COMPARATOR
Intervention: Standard temperature dialysate
Number of subjects: 15413
Study 32086787 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-month dual antiplatelet therapy (DAPT)
Number of subjects: 3009
Study 32238172 — intervention group
Group type: EXPERIMENTAL
Intervention: UA-ADRCs (11.4 × 10^6 cells in 5 mL liquid; mean cell viability: 88%)
Number of subjects: 16
Study 32238172 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid injection (80 mg of methylprednisolone plus 3 mL of 0.25% bupivacaine)
Number of subjects: 16
Study 34868484 — intervention group
Group type: EXPERIMENTAL
Intervention: Online Narrative Exposure Therapy (eNET) - 8-12 sessions of 90 minutes each conducted via video calls with trained paraprofessionals.
Number of subjects: 50
Study 34868484 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group receiving the same intervention after a three-month wait period.
Number of subjects: 50
Study 34868484 — intervention group
Group type: EXPERIMENTAL
Intervention: eNET intervention
Number of subjects: 50
Study 33958864 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 136
Study 33958864 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 136
Study 32075845 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement combination containing Boswellia serrata extract, pine bark extract, methylsulfonylmethane, and curcumin
Number of subjects: 106
Study 32075845 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 32075845 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement combination
Number of subjects: 106
Study 616121612 — intervention group
Group type: EXPERIMENTAL
Intervention: 15-mm Jupiter scleral lens worn for 2 hours
Number of subjects: 26
Study 616121612 — intervention group
Group type: COMPARATOR
Intervention: Control eye (no lens worn)
Number of subjects: 26
Study 36375147 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Ankle Replacement (TAR)
Number of subjects: 303
Study 36375147 — intervention group
Group type: COMPARATOR
Intervention: Ankle Fusion (AF)
Number of subjects: 303
Study 33638918 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiration chamber tests
Number of subjects: 30
Study 33638918 — intervention group
Group type: COMPARATOR
Intervention: Face mask tests
Number of subjects: 30
Study 32153793 — intervention group
Group type: EXPERIMENTAL
Intervention: NT‐proBNP ≥900 ng/L
Number of subjects: 93
Study 35781768 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-Screening (PS)
Number of subjects: 1034
Study 35781768 — intervention group
Group type: COMPARATOR
Intervention: Family-History (FH)
Number of subjects: 1034
Study 33796978 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk adolescents (15% highest scoring on SDQ-Y)
Number of subjects: 1022
Study 33796978 — intervention group
Group type: COMPARATOR
Intervention: Low-risk adolescents (85% lowest scoring on SDQ-Y)
Number of subjects: 1022
Study 32152495 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal antidepressant use during pregnancy
Number of subjects: 120
Study 32152495 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antidepressant use)
Number of subjects: 120
Study 35237948 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill-based gait slip training (N = 73), 40 unpredictable treadmill slips
Number of subjects: 143
Study 35237948 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 70), walked on a treadmill at comfortable speed
Number of subjects: 143
Study 32268649 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention combining clinical preventive services and lifestyle adjustment
Number of subjects: 3706
Study 32268649 — intervention group
Group type: COMPARATOR
Intervention: Routine chronic disease management (Control)
Number of subjects: 3706
Study 32268649 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive intervention
Number of subjects: 3706
Study 35345983 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory heat education intervention
Number of subjects: 83
Study 35345983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 83
Study 33954997 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-compliant balloon (SCB)
Number of subjects: 251
Study 33954997 — intervention group
Group type: COMPARATOR
Intervention: Non-compliant balloon (NCB)
Number of subjects: 251
Study 32382556 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (DEX)
Number of subjects: 60